Sumitomo Dainippon Pharma Financials
DNPUFDelisted Stock | USD 4.37 0.00 0.00% |
Sumitomo |
Understanding current and past Sumitomo Dainippon Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sumitomo Dainippon's financial statements are interrelated, with each one affecting the others. For example, an increase in Sumitomo Dainippon's assets may result in an increase in income on the income statement.
Sumitomo Dainippon Stock Summary
Sumitomo Dainippon competes with Hypera SA, Cumberland Pharmaceuticals, Orexo AB, C21 Investments, and Alpha Teknova. Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
Business Address | 6-8, Doshomachi 2-chome, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.sumitomo-pharma.com |
Phone | 81 6 6203 5321 |
Currency | USD - US Dollar |
Sumitomo Dainippon Key Financial Ratios
There are many critical financial ratios that Sumitomo Dainippon's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Sumitomo Dainippon Pharma reports annually and quarterly.Return On Equity | -0.0399 | |||
Return On Asset | -0.0075 | |||
Beta | 0.31 | |||
Last Dividend Paid | 28.0 |
Sumitomo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sumitomo Dainippon's current stock value. Our valuation model uses many indicators to compare Sumitomo Dainippon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sumitomo Dainippon competition to find correlations between indicators driving Sumitomo Dainippon's intrinsic value. More Info.Sumitomo Dainippon Pharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sumitomo Dainippon's earnings, one of the primary drivers of an investment's value.Sumitomo Dainippon Market Pulse
Quote | 4.37 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 4.37 |
Low | 4.37 |
High | 4.37 |
Volume | 0 |
Exchange | PINK |
Sumitomo Dainippon January 2, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sumitomo Dainippon help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sumitomo Dainippon Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sumitomo Dainippon Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Sumitomo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sumitomo Dainippon's daily price indicators and compare them against related drivers.
Information Ratio | (0.66) | |||
Maximum Drawdown | 15.18 | |||
Value At Risk | (9.83) | |||
Potential Upside | 1.97 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Sumitomo Pink Sheet
If you are still planning to invest in Sumitomo Dainippon Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sumitomo Dainippon's history and understand the potential risks before investing.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |